Department of Surgery

gradient
Surgeon Photo Department of Surgery

Research & Publications

< Main Research Page

Pancreas Club Poster Presentations

DDWOn May 20, 2007, Faculty and Housestaff in the Department of Surgery presented 9 posters and 3 oral presentations at the Pancreas Club's 41st Annual Meeting held at Children's National Medical Center in Washington DC. This event was held as a part of Digestive Disease Week - the world's largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

In addition, 2 of the Pancreas Club presentations by Drs. Arafat and Brody were presented at the Society for Surgery of the Alimentary Tract (SSAT) meeting one day later.

Click the Title to view the abstracts:

Hwyda Arafat

Hwyda Arafat, MD, PhD

Angiotensin II induces Vascular Endothelial Growth Factor in Pancreatic Cancer Cells Through an Angiotensin II Type 1 Receptor and ERK1/2 Signaling

Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA

Robert Adamo Poster

Robert Adamo, MD

Solitary Renal Cell Carcinoma Metastatic to Duodenum Treated by Classic Pancreatico-duodenectomy: A Case Report

Adamo R, Greaney P Jr., Witkiewicz A, Kennedy E, Yeo CJ

Adam Berger Poster

Adam Berger, MD

Impact of Obesity on Perioperative Morbidity and Mortality Following Pancreaticoduodenectomy

Berger A, Rosato E, Kennedy E, Chojnacki K, Doria C, Sauter P, Rosenberg L, Yeo CJ

Jonathan Brody, PhD

Jonathan Brody, PhD

A New Classification of Thymidylate Synthase Gene Copy Number Changes in Pancreatic Ducta Adenocarcinomas to Predict Response to 5 Flourouracil Based Therapy

Brody JR1, Hucl T2, Gallmeier E2, Winter JM2, Yeo, CJ1, Kern SE2, Murphy KM2

A Proposed Clinical Assay to Predict 5-Flourouracil Efficacy Against Pancreatic Ductal Adenocarcinoma by Utilizing a Pre-operative Dose OF Xeloda

Brody JR1, Hucl T2, Gallmeier E2 , Yoshimura K2, Schulick RD2, Hruban R2, Feeney K1, Kern SE2, Yeo CJ1

Expression and Role of the Tumor Suppressor pp32 in Pancreatic Tumorigenesis

JR Brody, Witkiewicz A, Cozzitorto J, Yeo CJ

Thomas Jefferson University1, Philadelphia, PA and Johns Hopkins University2, Baltimore, MD


Karen Chojnacki, MD

Karen Chojnacki, MD

Pancreatic VIPomas: Subject Review and One Institutional Experience

Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ

Eugene Kennedy

Eugene Kennedy, MD

A Case of Lymphoplasmacytic Sclerosing Pancreatitis with Concurrent Invasive Pancreatic Adenocarcinoma

Kennedy E, Witkiewicz A, Kenyon L, Hruban RH, Yeo CJ

Relationship Between Preoperative Hemoglobin A1c and Complications Following Pancreaticoduodenectomy

Kennedy E, Sauter, P, Rosenberg L, Yeo, CJ

 

Matthew Levy

Matthew Levy, MD

ZD6474 (Zactima TM), an inhibitor of VEGRF and EGRF tyrosine kinases, inhibits downstream signaling pathways and growth of pancreatic cancer cells

Levy M, Wachsberger P, Ngoubilly N, Pucci M, Yeo CJ, Lanza-Jacoby S

Fracis Rosato, Jr.

Francis Rosato Jr, MD

Symptomatic Minor Papilla Adenoma in Association with Pancreas Divisum

Rosato F Jr, Profeta B, Chojnacki K, Rosato E

Ernest Rosato

Ernest Rosato, MD

Intraoperative Radiation Therapy for Resected Pancreatic Cancer

Kemac K, Ormont M, Chojnacki K, Berger A Anne PR, Rosato E